Bridging tumor moats with potent drug delivery particles
Despite herculean efforts, cancer remains a formidable disease, with each malignant subtype responding differently to therapeutics. One hurdle specific to treating solid tumors is a...
Despite herculean efforts, cancer remains a formidable disease, with each malignant subtype responding differently to therapeutics. One hurdle specific to treating solid tumors is a...
DENVER -Elderly patients with stage III non-small cell lung cancer (NSCLC) showed improved overall survival (OS) when treated with chemoradiation (CRT) compared to definitive radiation...
Dying cancer patients given fluids will generally live longer, a new study led by researchers from Royal Surrey County Hospital NHS Foundation Trust and the...
In a retrospective analysis of 73 lung squamous cell carcinoma patients treated with the chemotherapy regimen of gemcitabine plus cisplatin, higher body mass index and...
In a retrospective analysis of 73 lung squamous cell carcinoma patients treated with the chemotherapy regimen of gemcitabine plus cisplatin, higher body mass index and...
A new review of published studies indicates that distress and neuroticism at or within 3 months of cancer diagnosis may predict emotional distress at least...
In the last few decades, dozens of new breast cancer drugs -- from chemotherapies to targeted compounds -- have become available for clinical use, and...
NEW VERSION: SOME CHANGES IN ENGLISH TRANSLATION OF THE QUOTATIONS Nowadays, melanoma and lung cancer can be combatted effectively through immunotherapy, which makes use of...
NEW VERSION: SOME CHANGES IN ENGLISH TRANSLATION OF THE QUOTATIONS Nowadays, melanoma and lung cancer can be combatted effectively through immunotherapy, which makes use of...
PRESS REGISTRATION: Credentialed Reporters and Public Information Officers May Register Here: https://www.eurekalert.org/aaasnewsroom/2018/registration/ AUSTIN, TEXAS--Regenerating organs for patie..
Outcomes for children and older adults with cancer have improved greatly over the past three decades, but there's been little improvement in survival among adolescents...
Outcomes for children and older adults with cancer have improved greatly over the past three decades, but there's been little improvement in survival among adolescents...
CINCINNATI--Researchers at the University of Cincinnati College of Medicine have identified for the first time that the estrogen receptor-binding protein MED1 is a critical mediator...
PRESS REGISTRATION: Credentialed Reporters and Public Information Officers May Register Here: https://www.eurekalert.org/aaasnewsroom/2018/registration/ AUSTIN, TEXAS--Regenerating organs for patie..
LOS ANGELES - A team of scientists at the Keck School of Medicine of USC is looking to some deep sea dwellers to create a...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.